Results 201 to 210 of about 65,941 (263)

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

ACE-Inhibitory Peptides from Yanbian Cattle Hemoglobin: Screening, Kinetics, and Molecular Dynamics Simulation. [PDF]

Foods
Yang S, Gao T, Qin B, Li C, Piao C, Cui M, Li H, Mu B, Wang J, Li T, Jiang Q, Lv A, Li G.   +12 more
europepmc   +1 more source

Solvent alternation of the antimicrobial, antioxidant, anticancer activities and chemical profiles of Trametes hirsuta (Wulfen) Lloyd. [PDF]

BMC Microbiol
Ahmed YM, Abdelaziz AM, El-Sheikh HH, Younis AM.   +3 more
europepmc   +1 more source

Isolation, Purification, Identification, and In Vitro ACE Inhibitory Activity of Tyrosine-Arginine Dipeptide From Red Millet Huangjiu. [PDF]

Food Sci Nutr
Li J, Zhong J, Zhang X.
europepmc   +1 more source

Innovative discovery and validation of ACE-inhibitory peptides from eggshell membrane keratin byproducts: An integrated computational and <i>in vitro</i> approach. [PDF]

Curr Res Food Sci
Xu T, Yang J, Gong L, Li H, Zhao K, Wang Z, Tang H.   +6 more
europepmc   +1 more source

The In Vitro Multifaceted Biological Activity of Catechins in Relation to Their Oxidation Potentials. [PDF]

Molecules
Wronkowska M, Zielińska D, Starowicz M, Szydłowski M, Piskuła MK, Zieliński H.   +5 more
europepmc   +1 more source

Myocardial perfusion and ACE inhibition.

Reviews in cardiovascular medicine, 2003
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

ACE inhibition and atherogenesis

Canadian Journal of Physiology and Pharmacology, 2002
Recent clinical studies such as HOPE, SECURE, and APRES show that angiotensin-converting enzyme (ACE) inhibitors like ramipril improve the prognosis of patients with a high risk of atherothrombotic cardiovascular events. Atherosclerosis, as a chronic inflammatory condition of the vascular system, can turn into an acute clinical event through the ...
B A, Schölkens, W, Landgraf
openaire   +3 more sources

Cardiac Effects of ACE Inhibition

Journal of Cardiovascular Pharmacology, 1993
Hypertension frequently is associated with a number of changes in heart structure and function, such as left ventricular hypertrophy, disturbed diastolic function, and subnormal stroke volume during exercise. Most of these changes probably are related to myocardial fibrosis.
P, Lund-Johansen, P, Omvik
openaire   +2 more sources

Clinical Pharmacology of ACE Inhibition

Cardiology, 2008
The radioimmunological determinations of immunoreactive ‘angiotensin IF do not truly reflect angiotensin-(l-8)octapeptide levels, and thus cannot provide an accurate reflection of the efficacy of angiotensin-converting enzyme (ACE) inhibition. Elaborate methods are necessary to measure specifically the octapeptide angiotensin II.
Nussberger J, Waeber B, Brunner HR
openaire   +3 more sources